Vyvanse supply issues ease

Supply issues impacting ADHD medication Vyvanse are set to return to normal by the end of the month  Takeda Pharmaceuticals Australia is reporting that shortages of Vyvanse (lisdexamfetamine dimesilate) are easing, with supply of the 30mg and 50mg products deemed to have been “resolved”.   However, the company advised the Therapeutic Goods Administration (TGA) that 40mg

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Poll: Should nicotine vapes be Pharmacist Only?
Next World news wrapup: 18 April 2024